Serraflazyme
Product Overview
Brand: Cardiovascular Research
Net Contents: 100 Tablet(s)
Serving Size (Overview): 1 Tablet(s)
Product Type: Non-Nutrient/Non-Botanical [A1309]
Form: Tablet or Pill [E0155]
Date Entered: Jun 25, 2013
Market Status: On Market
Suggested Use (Overview): DIRECTIONSTake one to four tablets daily; preferably before meals; or as directed by a physician.
Product Self-Roles:
- No specific self-roles defined.
Dietary Supplement Facts
| Ingredient | Category | Amount Per Serving | Unit | % Daily Value | Target Group | Serving Size (Fact) |
|---|---|---|---|---|---|---|
| Serrapeptase | enzyme | 5 | mg | N/A | Adults and children 4 or more years of age | 1 Tablet(s) |
Other Ingredients
Microcrystalline Cellulose; Calcium Phosphate (Ca Phosphate); Hydroxypropyl Methylcellulose; Silicon Dioxide (SiO2); Magnesium Stearate; Sodium Alginate; Stearic Acid (C18:0); Ethylcellulose; Ammonium Hydroxide; Medium Chain Triglycerides; Oleic Acid (C18:1n-9; OA)
Label Statements
Formulation
- Serrapeptase Enzyme (Serratio Peptidase) SERRAFLAZYME contains 5 mg of the purified enzyme Serratio Peptidase in an enterically-coated tablet. Free of yeast corn wheat sugar starch phenols egg milk and other common food and chemical allergens.
Statement of Identity
- Dietary Supplement A DIETARY SUPPLEMENT This product has not been evaluated by the FDA. This product is not intended to diagnose cure treat or prevent any disease.
Suggested Use
- DIRECTIONSTake one to four tablets daily preferably before meals or as directed by a physician.
Seals/Symbols
- ECOLOGICAL FORMULAS
Other
- 10090891 EXP0913 This preparation is scientifically designed for maximal absorption.
Associated Company Information & Roles
CARDIOVASCULAR RESEARCH LTD.
1061-B Shary Circle,
Concord,
CA
94518
Roles for this Product:
- Distributor